DEVICE RESEARCH
Principal Investigator Across Cypher Trial
Sub-Investigator ACS Multi-Link Stent Trial Principal Investigator – ACS Rx
Principal Investigator ACT-One Trial, Abbott Vascular Angio-Seal Trial
Principal Investigator ACT 1, Carotid Angioplasty and Stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid
endarterectomy with significant extracranial carotid stenotic disease, Abbott Vascular
Principal Investigator ARMOUR Study, proximal protection with the MO.ma device during carotid stenting, Invatec
Principal Investigator AVERT, Osprey Medical
Principal Investigator Balloon Expandable Intraluminal Stent for Subtotally Occluded Iliac Arteries
Principal Investigator Bard® Memotherm Carotid Stent Study
Principal Investigator BARRICADE Randomized Trial – The Barrier Approach to Restenosis: Restrict Intima and Curtail Adverse Events (JOMED JOSTENT)
Principal Investigator BEST Trial
Principal Investigator BetaCath System Trial
Principal Investigator Boehringer Ingelheim Pharmaceutics Protocol Comparing Micardis And COZAAR
Principal Investigator Boomerang, Cardiva Medical
Principal Investigator CABERNET Clinical Trial – Carotid Artery Revascularization using the Boston Scientific EPI FilterWire EX™ and the EndoTex™
NexStent™
Principal Investigator CADILLAC Trial
Principal Investigator CAPRICORN Trial
Principal Investigator CAPTIVE – Cardioshield Application Protects During Transluminal Intervention of Vein Grafts by Reducing Emboli
Principal Investigator CAPTURE 2 Trial, Guidant
Principal Investigator CARDIOMETRICS
Principal Investigator Carotid Wallstent Trial
Principal Investigator CAVEAT II Trial
Principal Investigator CHAMPION PHOENIX, Cangrelor vs Standard Therapy to Achieve optimal Management of Platelet Inhibition, The Medicines Co
Principal Investigator CHOCOLATE BAR, The chocolate Balloon Angioplasty Registry, TriReme Medical, Inc
Principal Investigator Clinical Investigation of the Magnum Wire vs. Standard Guide Wires During Total Occlusion Angioplasty
Principal Investigator Closure I Trial
Principal Investigator CHOICE Carotid Stent Trial, Abbott Vascular
Principal Investigator Carotid Stenting for High-Surgical Risk Patient; Evaluating Outcomes Through the Collection of Clinical Evidence --> Abbott Vascular
Principal Investigator COMBAT Trial
Principal Investigator CONFIDENCE study: Carotid stent trial to evaluate the safety and efficacy of the Roadsaver stent used in conjunction with
Nanoparasol embolic protection system for patients at increased risk of adverse events from carotid endarterectomy;
Microinvention, Inc.
Principal Investigator CONNECT, Chronic Total Occlusion Crossing with the Wildcat Catheter, Avinger
Principal Investigator Cook GR II Trial
Principal Investigator CORDIS Nitinol Carotid Stent and Delivery System for the Treatment Of Obstructive Carotid Artery Disease
Principal Investigator Cordis Carotid Randomized Sapphire
Principal Investigator Cordis Bilateral AAA Device and Delivery System
Principal Investigator (CATS) Safe-Steer™ Wire System Coronary Artery Total Occlusion Study
Principal Investigator CREATE PAS, Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study, Ev3, Inc
Principal Investigator CREATE Trial, Ev3
Principal Investigator CREDO Trial Director CrossLock Study
Principal Investigator Novaste CUP Trial
Principal Investigator CVD Accucath Infusion Catheter
Principal Investigator Duett Closure Device
Principal Investigator DURABILITY PAS, Post Approval Study, Covidien
Sub-Investigator ECLIPSE study: Evaluation of treatment for severe calcific coronary Arteries: Orbital atherectomy vs conventional angioplasty
technique prior to implantation of drug-eluting stents; CSI Cardiovascular Systems, Inc.
Principal Investigator ENDEAVOR IV Trial
Principal Investigator EndoSonics Cath Scanner Oracle – PTCA Catheter
Principal Investigator ENOVUS Trial
Principal Investigator EPI FilterWire Ex™ System during Transluminal Intervention of Saphenous Vein Grafts
Principal Investigator EXACT Carotid Stent Trial, Abbott Vascular
Principal Investigator EXPERT CTO, Evaluation of the XIENCE Coronary Stent, Performance and Technique in Chronic Total Occlusion, Abbott Vascular
Principal Investigator EXTRA Stent
Principal Investigator FACTOR Trial
Principal Investigator FAST CTO, BridgePoint Medical
Principal Investigator GE-145-002, GE Healthcare
Principal Investigator GEM-REM, A PI initiated proof-of-concept study to determine whether generative model-based resource efficient ecg monitoring
(GEM-REM) electrocardiogram monitoring is at least as diagnostically effective in terms of signal quality as traditional monitoring
techniques used in hospital settings, Arizona State University
Principal Investigator GREAT – Guided Radio Frequency Energy Ablation of Total
Occlusions Using the Safe-Cross™ Radio Frequency Total Occlusion Crossing System
Principal Investigator GRIP – Guided Radio Frequency in Peripheral Total Occlusions Crossing System Using the Safe-Cross™ Total Occlusion (TO)
Crossing System
Principal Investigator HIPS Trial
Principal Investigator Human Percutaneous Laser Angioplasty of the Coronary Arteries
Principal Investigator IMPROVE IT Trial
Sub-Investigator ISR 14-04: Post-Approval Study of the GORE VIABAHN Endoprosthesis for the Treatment of In-Stent Restenosis in the SFA; W. Gore
& Associates, Inc
Principal Investigator JET Registry, Jetstream NAVITUS System Endovascular Therapy Post-Market Registry, Medrad, Inc
Principal Investigator JET STREAM 2, Pathway Medical
Principal Investigator Johnson & Johnson Intracoronary Stent Program Supplement #27 New Delivery System
Principal Investigator Kensey Nash Hemostatic Puncture Closure Device
Sub-Investigator LIBERTY 360. Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic
Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD); CSI Cardiovascular
Systems, Inc
Principal Investigator LIFE Study. Least Invasive Fast-Track EVAR with the Ovation Prime Abdominal Stent Graft System; Trivascular, Inc.
Principal Investigator Mansfield-Boston Scientific Strecker Coronary Stent
Principal Investigator Medtronic AVE S7 with Discrete Technology Coronary Stent System
Principal Investigator Medtronic AVE S7 Coronary Stent Registry
Principal Investigator MIST II Trial, NMT Medical MAVERICK Carotid Stent Study, Medtronic AVE
Principal Investigator MOBILE Trial – More Patency with beta for In-Stent Restenosis in the Lower Extremities Trial IDE #G010295; Protocol D00789 Rev B
Dated 12/01
Principal Investigator NIR Stent Trial
Principal Investigator Neurex/Elan Pharmaceuticals Trial
National Co-PI OASIS Trial, CSI
Principal Investigator PFAST-CTO, Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions Study, BridgePoint, Medical
Principal Investigator PAMI Stent Trial
Principal Investigator Paragon Stent
Principal Investigator Paris Radiation Trial
Principal Investigator PaS Trial
Principal Investigator Percutaneous Recanalization of Stenotic Human Coronary Arteries with Balloon Expandable Intracoronary Stents
Principal Investigator Percutaneous Recanalization of Stenotic Human Saphenous Vein Bypass Graft with Balloon Expandable Intraluminal Stents
Principal Investigator Percutaneous Thermal Balloon Angioplasty
Sub-Investigator PLATINUM Diversity Study. Outcomes with the Promus PREMIER™ Stent in Women and Minorities; Boston Scientific
Principal Investigator PMR Trial
Principal Investigator Pravastatin or Atorvastatin Evaluation and Infection Therapy (Prove It)
Principal Investigator PRESERV, Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney Trial,
Osprey Medical
Principal Investigator PROXIMAL Trial
Principal Investigator Presto Trial
Principal Investigator RAVES Trial, PROGUARD, Kensey Nash Corporation
Principal Investigator PROSPECT Trial
Principal Investigator RESCUE Trial
Principal Investigator RESOLUTE US, Medtronic Vascular
Principal Investigator SAFE-DCB: A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated
Balloon Catheter in Arteries of the SFA and Popliteal Artery; C.R. Bard
Principal Investigator SAFER – Saphenous Vein Graft Angioplasty Free of Emboli Randomized Study Using the PercuSurge Guard Wire™ System
Principal Investigator SAVED Trial
Principal Investigator SAPPHIRE Trial, Cordis, SAPPHIRE WN, Cordis
Principal Investigator Schering-Plough Phase III Study of SCH 58235 in addition to Pravastatin compared to placebo in subject with primary
hypercholesterolemia
Principal Investigator Long-Term, Open-Label, Safety and Tolerability Study of SCH 58235 in addition to Pravastatin in Patients with Primary
Hypercholesterolemia
Principal Investigator Schneider WINS Trial
Principal Investigator SCORES Trial
Principal Investigator Sepracor Study of Norastemizole in Cardiac Compromised Subjects
Principal Investigator SMART Trial (National PI)
Principal Investigator SMART: Post-Approval Study
Principal Investigator SOAR – Renal Stent, SONOMA, Boston Scientific
Principal Investigator SONOMA, Boston Scientific
Principal Investigator Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 376/95 Compared with Dose-Adjusted Warfarin (Coumadin) in
the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V)
Principal Investigator STARS Trial
Principal Investigator START Trial (National PI)
Principal Investigator STRATUS Trial
Principal Investigator STRESS III Trial
Principal Investigator SUMO Trial
Principal Investigator (SWING) Sound Wave Inhibition of Neointimal Growth
Principal Investigator Talent Endoluminal Graft (High Risk & Low Risk)
Principal Investigator Talent Endoluminal Spring Stent-Graft System
Principal Investigator TAMARIS, Sanofi Aventis
Principal Investigator Tenax-XR Coronary Stent System
Principal Investigator TITAL Trial
Principal Investigator Trimedyne Excimer Laser Assisted Percutaneous Coronary Angioplasty
Principal Investigator Trimedyne Percutaneous Eclipse Holmium Laser Coronary Angioplasty
Principal Investigator Transvivo Trial
Principal Investigator VeGAS 2 Trial
Director Verve Medical Device Study
Sub-Investigator VIAGAHN BX. Evaluation of the Gore VIABAHN Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of
Occlusive Disease in the Common and External Iliac Arteries; W.L. Gore and Associates, Inc.
Sub-Investigator VIABAHN BX: Evaluation of the GORE VIABAHN BALLOON EXPANDABLE EDOPROSTHESIS for the treatment of occlusive
disease in the Common and External Iliac Arteries; W.L. Gore & Associates, Inc.
Principal Investigator VIVA Carotid Stent Trial, CR Bard
Principal Investigator Volcano Registry Trial
Principal Investigator Volocity Trial Principal Investigator – Venus Stent
Principal Investigator WALLSTENT Study
Principal Investigator WIKTOR Coronary Stent
PHARMACOLOGY RESEARCH
Principal Investigator Abbott rUK Trial
Principal Investigator Ajinimoto Pharmaceuticals Double-Blind Placebo-Controlled Study of AT-1015 in Patients with Intermittent Claudication due to
Peripheral Artery Disease
Principal Investigator Amgen, Inc., Anakinra Trial for Rheumatoid Arthritis
Principal Investigator AstraZeneca Pharmaceutical Trial to Evaluate the Safety and Efficacy XXXX and Atorvastatin
Principal Investigator AstraZeneca Trial Open label Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin,
Pravastatin and Simvastatin in Subjects with Hypercholesterolemia
Principal Investigator Parke-Davis and Pfizer Randomized Open-Label Study Comparing the Efficacy of Once Daily Atorvastatin to Simvastatin in
Hypercholesterolemic Patients
Principal Investigator Pilot Study to Evaluate Intracoronary Administration of Activase for the Treatment of Intracoronary Thrombus
Principal Investigator Artistic Trial
Principal Investigator AstraZeneca Trial of Niaspan versus New Generation Statin for the Treatment of Type IIB and Type IV Hyperlipidemia
Principal Investigator AstraZeneca Multicenter Trial for Drug (XXX) and Atorvastatin for the Treatment of Hypercholesterolemia
Principal Investigator BRAVO Trial
Principal Investigator BioVail Angina and Hypertension Trial
Principal Investigator CAMPER Trial
Principal Investigator CAPRICORN Trial
Principal Investigator Challenge Trial
Principal Investigator CHAMPION PCI Trial
Principal Investigator Centocor Chimeric 7E3 Fab
Sub-Investigator Comparison of Lopentol and Omnipaque in Adult Angiocardiography
Sub-Investigator Comparison of Intravenous Adenosine to Intravenous Placebo in Termination of Spontaneous or Induced Paroxysmal
Supraventricular Tachcardia
Principal Investigator CONNECT Trial
Principal Investigator COR Therapeutics Randomized Placebo-Controlled Dose Ranging Study of Drug (XXXX) in Patients with Atherosclerotic
Cardiovascular, Peripheral Vascular and/or Cerebrovascular Disease
Sub-Investigator Dose Response Study of Bucindolol in Patients with Congestive Heart Failure
Principal Investigator Effects of Recombinant Human Superoxide Dismutase in Patients with Acute Myocardial Infarction Subject to Coronary Artery
Reperfusion
Sub-Investigator Eli Lilly – Agitation/Alzheimer’s Trial
Principal Investigator EPILOG Trial
Principal Investigator ERASER Trial
Principal Investigator GUSTO Trial
Principal Investigator A Multi-Center, Randomized, Double-Blind, Placebo-and-Active Controlled Parallel Group Dose-Ranging Study of the HMG CoA
Reductase Inhibitor, BMS-423526, in the Treatment of Hyperlipidemia
Principal Investigator Study Lovastatin XL with MEVACOR in Patients with Hypercholesterolemia
Sub-Investigator Lovastatin Multi-Center Trial
Principal Investigator Extended Trial of Lovastatin XL for the Treatment of Hypercholesterolemia
Principal Investigator Multi-Center Double-Blind Placebo Controlled Trial of Drug (XXXX) In Patients with Type 2 Diabetes and Congestive Heart Failure
Principal Investigator Effect of LDL-Cholesterol Lowering Beyond Currently Recommended
Minimum Targets on Coronary Heart Disease (CHD) Recurrence in Patients with Pre-Existing CHD
Principal Investigator A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Dosing Study Evaluating the Effects of Nebivolol on
Blood Pressure in Patients with Mild to Moderate Hypertension, NEB 302
Principal Investigator Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients with Mild to
Moderate Hypertension NEB 306
Principal Investigator NeoTherapeutics Alzheimer’s Disease 2000
Principal Investigator NeoTherapeutics Alzheimer’s Disease 2001
Principal Investigator OCTAVE Trial
Sub-Investigator OCTAVE Trial
Principal Investigator Pfizer Phase II Multi-Center, Double-Blind Placebo-Controlled Randomized Parallel Group Ranging Study of the Safety of CP529,
414 Soft-Gel capsules
Principal Investigator PLATA, AstraZeneca
Principal Investigator PLAC Trial
Principal Investigator Protocol 073 Trial
Principal Investigator Knoll Pharmaceutical Double-Blind Randomized Clinical Trial of Slow
Release Propafenone (Rythmol-SR)®) in the Prevention of Symptomatic Recurrences of Atrial Fibrillation
Principal Investigator PREVAIL – A Phase 2 Multi-Center, Double-Blind Placebo-Controlled,
Dose-Ranging Study to Evaluate the Safety and Efficacy of BO-653 in Prevention of Post=Angioplasty Restenosis in Stented Lesions
Principal Investigator PROVE-IT TIMI 22 – Pravastatin or Atorvastatin Evaluation and Infection Therapy
Principal Investigator PURSUIT Trial
Principal Investigator QUIET Trial
Principal Investigator RAFT Trial
Principal Investigator REPLACE Randomized Evaluation in PCI Linking Angiomax to Reduce Clinical Events
Principal Investigator RESOLUTE Trial
Sub-Investigator Safety and Efficacy Study of Burroughs – Wellcome Tissue Plasminogen Activator in Patients with Acute Myocardial Infarction
Principal Investigator A 6-Week, Open-Label, Dose-Comparison Study to Evaluate the Safety
and Efficacy of Rosuvastatin versus Atorvastatin, Cerivastatin, Pravastatin and Simvastatin in Subjects with Hypercholesterolemia
Principal Investigator A 48-Week, Open-label, Non-comparative, Multi-center, Phase IIIb Study to Evaluate the Efficacy and Safety of the Lipid-Regulating
Agent Rosuvastatin in the treatment of Subjects with Fredrickson Type IIa and Type IIb Dyslipidemia, including Heterozygous
Familial Hypercholesterolemia
Principal Investigator SAGE Trial
Sub-Investigator Long Term Open Label Safety and Tolerability Study of SCH58235 in Addition to Pravastatin in Patients with Primary
Hypercholesterolemia
Principal Investigator Phase III Double-Blind Efficacy and Safety Study SCH58235 (10 mg)
in Addition to Pravastatin Compared to Placebo in Subjects with Primary Hypercholesterolemia
Principal Investigator Phase III Open Label Efficacy and Safety Study SCH58235 (10 mg)
in Addition to Pravastatin Compared to Placebo in Subjects with Primary Hypercholesterolemia
Sub-Investigator Protomyxzoa vascular study: Detection of protozoan-based biofilm Communities including protomyxzoa rheumatic (FL 1953) in
debris extracted in the normal course of cardiovascular suction atherectomy and related vascular clearance procedcures; Fry Labs
Principal Investigator Sepracor Protocol Study of Norastemizole in Cardiac Compromised Subjects
Principal Investigator SNAPIST – A Phase 2, Safety Study of Systematic Nanoparticle Paclitaxel (ABI-007) for In-Stent Restenosis; IND #63,082
Principal Investigator SPORTIF V – Atrial Fibrillation Trial
Principal Investigator SWORD Trial
Sub-Investigator TIMI 38 Trial
Principal Investigator Titration-to-Response Trial Comparing Micardis and COZAAR® in Patients with Mild-to-Moderate Hypertension
Principal Investigator TNT Trial
Principal Investigator TREND Trial
Principal Investigator ULTRASCORE Trial, A Prospective, Multi-Center, Single-Arm, Real- World Study Assessing Clinical Use of the Bard® UltraScolre™
Focused Force PTA Balloon, CR Bard
Sub-Investigator VALDECOXIB Trial
Principal Investigator An Open-Label, Multinational, Multi-Center, Extension Trial to Assess the Long-Term Safety and Efficacy of ZD4522 in Subjects in
the ZD4522 Clinical Trial Program
BASIC RESEARCH
1990 – 1993 Systematic assessment of Medtronic balloons and guiding catheters in porcine and Canine models. Sponsored by Medtronic, Inc.
1990 – 1993 Determination of radiopacity and torquability of Medtronic vascular catheters in Porcine models. Sponsored by Medtronic, Inc.
1990 – 1994 Evaluation of Japan Crescent radiofrequency balloon in porcine model with emphasis On Histopathology of heat-produced lesions. Abstract
submitted at 1993 AHA Conference.
1992 – 1996 Evaluation of Strecker in porcine and canine models. Sponsored by Boston Scientific. Evaluation of Wiktor stent and stent in porcine and canine
models. Sponsored by Medtronic, Inc. Evaluation of NIR stent in porcine models. Sponsored by Cordis Corp.
1993 Evaluation of radiofrequency wire for total coronary occlusions in porcine models: Determining energy limitations. Equipment subsequently
licensed to Radius Medical.
1994 – 1997 Training courses for professionals (physicians, engineers, technicians) in techniques and
Strategies for placement of coronary stents. Five courses sponsored by Johnson & Johnson, Medtronic, Inc., and Cook, Inc.
1997 Efficacy of the Endotex Abdominal Aortic Aneurysm exclusion device in a porcine
Model gauging ability to exclude renal arteries, ease of placement and radiopacity. Sponsored by Endotex.
1998 Use of percutaneous myocardial revascularization in a porcine model. Sponsored by ardiogenesis Corporation at Stanford University.
1998 – 1999 Utility of radiofrequency (RF) percutaneous myocardial revascularization in acute and chronic porcine model: Histopathology and angiogensis
related to use of RF alone and in combination with growth factor (VEGF). Results presented at Angiogenesis 1999, Washington, D.C.
1999 Development and testing of embolic probe device in porcine model. Performed at PRMC
And separately at Columbia Presbyterian in New York (Patent #6,364,900).
1999 Evaluation of the Medtronic carotid and SVG stent in porcine carotid and saphenous vein graft lesions assessing ease of use and 30-day
outcome. Sponsored by Medtronic, Inc.
1999 Development and testing of Protector vascular embolic protection device in porcine Model at Mayo Clinic (Patent #6,364,900).
1999 Evaluation of ability of intramuscular growth factor to stimulate angiogenesis in rabbit hindlimb model at 30 and 60 days post-procedure.
Sponsored by Sulzer Medical.
1999 Use of Vesseal device to close porcine peripheral artery tears (Patent #6,159,197). Sponsored by Phoenix Heart Center.
2004 Feasibility of device for fluid removal with porcine model. Sponsored by Transvivo, Inc.
2004 Feasibility of PVI in creating AV Fistulae with porcine model. Sponsored by PVI (Patent #6,464,665).
2005 PFO Closure with StarClose Device. Sponsored by NMT.
2006 New RF wire for coronary and peripheral arteries. Sponsored by Radius Medical.
2006 Snare evaluation for heart and neuro application. Sponsored by Radius Medical.
2007 Surrogate endpoints in PAD. Sponsored by TBD.
2007 PFO and Arrhythmias. Sponsored by Phoenix Heart Center.
2008 Porcine Ventricular Closure Star Close. Sponsored by Abbott.
2008 Ventricular Porcine Closure. Sponsored by Medtronic.
2008 Porcine Ventricular Closure. Sponsored by Edwards.
2008 Cerebral Canine studies. Sponsored by Atrium.
2008 Ventricular Closure with AngioLink.
2010 Transapical Closure in Sheep and Pigs. Access Closure, San Jose, California.
2010 Ventricular Closure Ovoic. Sponsored by Access Closure.
2011 Canine PFO. Sponsored by Gore.
Principal Investigator Across Cypher Trial
Sub-Investigator ACS Multi-Link Stent Trial Principal Investigator – ACS Rx
Principal Investigator ACT-One Trial, Abbott Vascular Angio-Seal Trial
Principal Investigator ACT 1, Carotid Angioplasty and Stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid
endarterectomy with significant extracranial carotid stenotic disease, Abbott Vascular
Principal Investigator ARMOUR Study, proximal protection with the MO.ma device during carotid stenting, Invatec
Principal Investigator AVERT, Osprey Medical
Principal Investigator Balloon Expandable Intraluminal Stent for Subtotally Occluded Iliac Arteries
Principal Investigator Bard® Memotherm Carotid Stent Study
Principal Investigator BARRICADE Randomized Trial – The Barrier Approach to Restenosis: Restrict Intima and Curtail Adverse Events (JOMED JOSTENT)
Principal Investigator BEST Trial
Principal Investigator BetaCath System Trial
Principal Investigator Boehringer Ingelheim Pharmaceutics Protocol Comparing Micardis And COZAAR
Principal Investigator Boomerang, Cardiva Medical
Principal Investigator CABERNET Clinical Trial – Carotid Artery Revascularization using the Boston Scientific EPI FilterWire EX™ and the EndoTex™
NexStent™
Principal Investigator CADILLAC Trial
Principal Investigator CAPRICORN Trial
Principal Investigator CAPTIVE – Cardioshield Application Protects During Transluminal Intervention of Vein Grafts by Reducing Emboli
Principal Investigator CAPTURE 2 Trial, Guidant
Principal Investigator CARDIOMETRICS
Principal Investigator Carotid Wallstent Trial
Principal Investigator CAVEAT II Trial
Principal Investigator CHAMPION PHOENIX, Cangrelor vs Standard Therapy to Achieve optimal Management of Platelet Inhibition, The Medicines Co
Principal Investigator CHOCOLATE BAR, The chocolate Balloon Angioplasty Registry, TriReme Medical, Inc
Principal Investigator Clinical Investigation of the Magnum Wire vs. Standard Guide Wires During Total Occlusion Angioplasty
Principal Investigator Closure I Trial
Principal Investigator CHOICE Carotid Stent Trial, Abbott Vascular
Principal Investigator Carotid Stenting for High-Surgical Risk Patient; Evaluating Outcomes Through the Collection of Clinical Evidence --> Abbott Vascular
Principal Investigator COMBAT Trial
Principal Investigator CONFIDENCE study: Carotid stent trial to evaluate the safety and efficacy of the Roadsaver stent used in conjunction with
Nanoparasol embolic protection system for patients at increased risk of adverse events from carotid endarterectomy;
Microinvention, Inc.
Principal Investigator CONNECT, Chronic Total Occlusion Crossing with the Wildcat Catheter, Avinger
Principal Investigator Cook GR II Trial
Principal Investigator CORDIS Nitinol Carotid Stent and Delivery System for the Treatment Of Obstructive Carotid Artery Disease
Principal Investigator Cordis Carotid Randomized Sapphire
Principal Investigator Cordis Bilateral AAA Device and Delivery System
Principal Investigator (CATS) Safe-Steer™ Wire System Coronary Artery Total Occlusion Study
Principal Investigator CREATE PAS, Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study, Ev3, Inc
Principal Investigator CREATE Trial, Ev3
Principal Investigator CREDO Trial Director CrossLock Study
Principal Investigator Novaste CUP Trial
Principal Investigator CVD Accucath Infusion Catheter
Principal Investigator Duett Closure Device
Principal Investigator DURABILITY PAS, Post Approval Study, Covidien
Sub-Investigator ECLIPSE study: Evaluation of treatment for severe calcific coronary Arteries: Orbital atherectomy vs conventional angioplasty
technique prior to implantation of drug-eluting stents; CSI Cardiovascular Systems, Inc.
Principal Investigator ENDEAVOR IV Trial
Principal Investigator EndoSonics Cath Scanner Oracle – PTCA Catheter
Principal Investigator ENOVUS Trial
Principal Investigator EPI FilterWire Ex™ System during Transluminal Intervention of Saphenous Vein Grafts
Principal Investigator EXACT Carotid Stent Trial, Abbott Vascular
Principal Investigator EXPERT CTO, Evaluation of the XIENCE Coronary Stent, Performance and Technique in Chronic Total Occlusion, Abbott Vascular
Principal Investigator EXTRA Stent
Principal Investigator FACTOR Trial
Principal Investigator FAST CTO, BridgePoint Medical
Principal Investigator GE-145-002, GE Healthcare
Principal Investigator GEM-REM, A PI initiated proof-of-concept study to determine whether generative model-based resource efficient ecg monitoring
(GEM-REM) electrocardiogram monitoring is at least as diagnostically effective in terms of signal quality as traditional monitoring
techniques used in hospital settings, Arizona State University
Principal Investigator GREAT – Guided Radio Frequency Energy Ablation of Total
Occlusions Using the Safe-Cross™ Radio Frequency Total Occlusion Crossing System
Principal Investigator GRIP – Guided Radio Frequency in Peripheral Total Occlusions Crossing System Using the Safe-Cross™ Total Occlusion (TO)
Crossing System
Principal Investigator HIPS Trial
Principal Investigator Human Percutaneous Laser Angioplasty of the Coronary Arteries
Principal Investigator IMPROVE IT Trial
Sub-Investigator ISR 14-04: Post-Approval Study of the GORE VIABAHN Endoprosthesis for the Treatment of In-Stent Restenosis in the SFA; W. Gore
& Associates, Inc
Principal Investigator JET Registry, Jetstream NAVITUS System Endovascular Therapy Post-Market Registry, Medrad, Inc
Principal Investigator JET STREAM 2, Pathway Medical
Principal Investigator Johnson & Johnson Intracoronary Stent Program Supplement #27 New Delivery System
Principal Investigator Kensey Nash Hemostatic Puncture Closure Device
Sub-Investigator LIBERTY 360. Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic
Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD); CSI Cardiovascular
Systems, Inc
Principal Investigator LIFE Study. Least Invasive Fast-Track EVAR with the Ovation Prime Abdominal Stent Graft System; Trivascular, Inc.
Principal Investigator Mansfield-Boston Scientific Strecker Coronary Stent
Principal Investigator Medtronic AVE S7 with Discrete Technology Coronary Stent System
Principal Investigator Medtronic AVE S7 Coronary Stent Registry
Principal Investigator MIST II Trial, NMT Medical MAVERICK Carotid Stent Study, Medtronic AVE
Principal Investigator MOBILE Trial – More Patency with beta for In-Stent Restenosis in the Lower Extremities Trial IDE #G010295; Protocol D00789 Rev B
Dated 12/01
Principal Investigator NIR Stent Trial
Principal Investigator Neurex/Elan Pharmaceuticals Trial
National Co-PI OASIS Trial, CSI
Principal Investigator PFAST-CTO, Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions Study, BridgePoint, Medical
Principal Investigator PAMI Stent Trial
Principal Investigator Paragon Stent
Principal Investigator Paris Radiation Trial
Principal Investigator PaS Trial
Principal Investigator Percutaneous Recanalization of Stenotic Human Coronary Arteries with Balloon Expandable Intracoronary Stents
Principal Investigator Percutaneous Recanalization of Stenotic Human Saphenous Vein Bypass Graft with Balloon Expandable Intraluminal Stents
Principal Investigator Percutaneous Thermal Balloon Angioplasty
Sub-Investigator PLATINUM Diversity Study. Outcomes with the Promus PREMIER™ Stent in Women and Minorities; Boston Scientific
Principal Investigator PMR Trial
Principal Investigator Pravastatin or Atorvastatin Evaluation and Infection Therapy (Prove It)
Principal Investigator PRESERV, Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney Trial,
Osprey Medical
Principal Investigator PROXIMAL Trial
Principal Investigator Presto Trial
Principal Investigator RAVES Trial, PROGUARD, Kensey Nash Corporation
Principal Investigator PROSPECT Trial
Principal Investigator RESCUE Trial
Principal Investigator RESOLUTE US, Medtronic Vascular
Principal Investigator SAFE-DCB: A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated
Balloon Catheter in Arteries of the SFA and Popliteal Artery; C.R. Bard
Principal Investigator SAFER – Saphenous Vein Graft Angioplasty Free of Emboli Randomized Study Using the PercuSurge Guard Wire™ System
Principal Investigator SAVED Trial
Principal Investigator SAPPHIRE Trial, Cordis, SAPPHIRE WN, Cordis
Principal Investigator Schering-Plough Phase III Study of SCH 58235 in addition to Pravastatin compared to placebo in subject with primary
hypercholesterolemia
Principal Investigator Long-Term, Open-Label, Safety and Tolerability Study of SCH 58235 in addition to Pravastatin in Patients with Primary
Hypercholesterolemia
Principal Investigator Schneider WINS Trial
Principal Investigator SCORES Trial
Principal Investigator Sepracor Study of Norastemizole in Cardiac Compromised Subjects
Principal Investigator SMART Trial (National PI)
Principal Investigator SMART: Post-Approval Study
Principal Investigator SOAR – Renal Stent, SONOMA, Boston Scientific
Principal Investigator SONOMA, Boston Scientific
Principal Investigator Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 376/95 Compared with Dose-Adjusted Warfarin (Coumadin) in
the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V)
Principal Investigator STARS Trial
Principal Investigator START Trial (National PI)
Principal Investigator STRATUS Trial
Principal Investigator STRESS III Trial
Principal Investigator SUMO Trial
Principal Investigator (SWING) Sound Wave Inhibition of Neointimal Growth
Principal Investigator Talent Endoluminal Graft (High Risk & Low Risk)
Principal Investigator Talent Endoluminal Spring Stent-Graft System
Principal Investigator TAMARIS, Sanofi Aventis
Principal Investigator Tenax-XR Coronary Stent System
Principal Investigator TITAL Trial
Principal Investigator Trimedyne Excimer Laser Assisted Percutaneous Coronary Angioplasty
Principal Investigator Trimedyne Percutaneous Eclipse Holmium Laser Coronary Angioplasty
Principal Investigator Transvivo Trial
Principal Investigator VeGAS 2 Trial
Director Verve Medical Device Study
Sub-Investigator VIAGAHN BX. Evaluation of the Gore VIABAHN Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of
Occlusive Disease in the Common and External Iliac Arteries; W.L. Gore and Associates, Inc.
Sub-Investigator VIABAHN BX: Evaluation of the GORE VIABAHN BALLOON EXPANDABLE EDOPROSTHESIS for the treatment of occlusive
disease in the Common and External Iliac Arteries; W.L. Gore & Associates, Inc.
Principal Investigator VIVA Carotid Stent Trial, CR Bard
Principal Investigator Volcano Registry Trial
Principal Investigator Volocity Trial Principal Investigator – Venus Stent
Principal Investigator WALLSTENT Study
Principal Investigator WIKTOR Coronary Stent
PHARMACOLOGY RESEARCH
Principal Investigator Abbott rUK Trial
Principal Investigator Ajinimoto Pharmaceuticals Double-Blind Placebo-Controlled Study of AT-1015 in Patients with Intermittent Claudication due to
Peripheral Artery Disease
Principal Investigator Amgen, Inc., Anakinra Trial for Rheumatoid Arthritis
Principal Investigator AstraZeneca Pharmaceutical Trial to Evaluate the Safety and Efficacy XXXX and Atorvastatin
Principal Investigator AstraZeneca Trial Open label Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin,
Pravastatin and Simvastatin in Subjects with Hypercholesterolemia
Principal Investigator Parke-Davis and Pfizer Randomized Open-Label Study Comparing the Efficacy of Once Daily Atorvastatin to Simvastatin in
Hypercholesterolemic Patients
Principal Investigator Pilot Study to Evaluate Intracoronary Administration of Activase for the Treatment of Intracoronary Thrombus
Principal Investigator Artistic Trial
Principal Investigator AstraZeneca Trial of Niaspan versus New Generation Statin for the Treatment of Type IIB and Type IV Hyperlipidemia
Principal Investigator AstraZeneca Multicenter Trial for Drug (XXX) and Atorvastatin for the Treatment of Hypercholesterolemia
Principal Investigator BRAVO Trial
Principal Investigator BioVail Angina and Hypertension Trial
Principal Investigator CAMPER Trial
Principal Investigator CAPRICORN Trial
Principal Investigator Challenge Trial
Principal Investigator CHAMPION PCI Trial
Principal Investigator Centocor Chimeric 7E3 Fab
Sub-Investigator Comparison of Lopentol and Omnipaque in Adult Angiocardiography
Sub-Investigator Comparison of Intravenous Adenosine to Intravenous Placebo in Termination of Spontaneous or Induced Paroxysmal
Supraventricular Tachcardia
Principal Investigator CONNECT Trial
Principal Investigator COR Therapeutics Randomized Placebo-Controlled Dose Ranging Study of Drug (XXXX) in Patients with Atherosclerotic
Cardiovascular, Peripheral Vascular and/or Cerebrovascular Disease
Sub-Investigator Dose Response Study of Bucindolol in Patients with Congestive Heart Failure
Principal Investigator Effects of Recombinant Human Superoxide Dismutase in Patients with Acute Myocardial Infarction Subject to Coronary Artery
Reperfusion
Sub-Investigator Eli Lilly – Agitation/Alzheimer’s Trial
Principal Investigator EPILOG Trial
Principal Investigator ERASER Trial
Principal Investigator GUSTO Trial
Principal Investigator A Multi-Center, Randomized, Double-Blind, Placebo-and-Active Controlled Parallel Group Dose-Ranging Study of the HMG CoA
Reductase Inhibitor, BMS-423526, in the Treatment of Hyperlipidemia
Principal Investigator Study Lovastatin XL with MEVACOR in Patients with Hypercholesterolemia
Sub-Investigator Lovastatin Multi-Center Trial
Principal Investigator Extended Trial of Lovastatin XL for the Treatment of Hypercholesterolemia
Principal Investigator Multi-Center Double-Blind Placebo Controlled Trial of Drug (XXXX) In Patients with Type 2 Diabetes and Congestive Heart Failure
Principal Investigator Effect of LDL-Cholesterol Lowering Beyond Currently Recommended
Minimum Targets on Coronary Heart Disease (CHD) Recurrence in Patients with Pre-Existing CHD
Principal Investigator A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Dosing Study Evaluating the Effects of Nebivolol on
Blood Pressure in Patients with Mild to Moderate Hypertension, NEB 302
Principal Investigator Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients with Mild to
Moderate Hypertension NEB 306
Principal Investigator NeoTherapeutics Alzheimer’s Disease 2000
Principal Investigator NeoTherapeutics Alzheimer’s Disease 2001
Principal Investigator OCTAVE Trial
Sub-Investigator OCTAVE Trial
Principal Investigator Pfizer Phase II Multi-Center, Double-Blind Placebo-Controlled Randomized Parallel Group Ranging Study of the Safety of CP529,
414 Soft-Gel capsules
Principal Investigator PLATA, AstraZeneca
Principal Investigator PLAC Trial
Principal Investigator Protocol 073 Trial
Principal Investigator Knoll Pharmaceutical Double-Blind Randomized Clinical Trial of Slow
Release Propafenone (Rythmol-SR)®) in the Prevention of Symptomatic Recurrences of Atrial Fibrillation
Principal Investigator PREVAIL – A Phase 2 Multi-Center, Double-Blind Placebo-Controlled,
Dose-Ranging Study to Evaluate the Safety and Efficacy of BO-653 in Prevention of Post=Angioplasty Restenosis in Stented Lesions
Principal Investigator PROVE-IT TIMI 22 – Pravastatin or Atorvastatin Evaluation and Infection Therapy
Principal Investigator PURSUIT Trial
Principal Investigator QUIET Trial
Principal Investigator RAFT Trial
Principal Investigator REPLACE Randomized Evaluation in PCI Linking Angiomax to Reduce Clinical Events
Principal Investigator RESOLUTE Trial
Sub-Investigator Safety and Efficacy Study of Burroughs – Wellcome Tissue Plasminogen Activator in Patients with Acute Myocardial Infarction
Principal Investigator A 6-Week, Open-Label, Dose-Comparison Study to Evaluate the Safety
and Efficacy of Rosuvastatin versus Atorvastatin, Cerivastatin, Pravastatin and Simvastatin in Subjects with Hypercholesterolemia
Principal Investigator A 48-Week, Open-label, Non-comparative, Multi-center, Phase IIIb Study to Evaluate the Efficacy and Safety of the Lipid-Regulating
Agent Rosuvastatin in the treatment of Subjects with Fredrickson Type IIa and Type IIb Dyslipidemia, including Heterozygous
Familial Hypercholesterolemia
Principal Investigator SAGE Trial
Sub-Investigator Long Term Open Label Safety and Tolerability Study of SCH58235 in Addition to Pravastatin in Patients with Primary
Hypercholesterolemia
Principal Investigator Phase III Double-Blind Efficacy and Safety Study SCH58235 (10 mg)
in Addition to Pravastatin Compared to Placebo in Subjects with Primary Hypercholesterolemia
Principal Investigator Phase III Open Label Efficacy and Safety Study SCH58235 (10 mg)
in Addition to Pravastatin Compared to Placebo in Subjects with Primary Hypercholesterolemia
Sub-Investigator Protomyxzoa vascular study: Detection of protozoan-based biofilm Communities including protomyxzoa rheumatic (FL 1953) in
debris extracted in the normal course of cardiovascular suction atherectomy and related vascular clearance procedcures; Fry Labs
Principal Investigator Sepracor Protocol Study of Norastemizole in Cardiac Compromised Subjects
Principal Investigator SNAPIST – A Phase 2, Safety Study of Systematic Nanoparticle Paclitaxel (ABI-007) for In-Stent Restenosis; IND #63,082
Principal Investigator SPORTIF V – Atrial Fibrillation Trial
Principal Investigator SWORD Trial
Sub-Investigator TIMI 38 Trial
Principal Investigator Titration-to-Response Trial Comparing Micardis and COZAAR® in Patients with Mild-to-Moderate Hypertension
Principal Investigator TNT Trial
Principal Investigator TREND Trial
Principal Investigator ULTRASCORE Trial, A Prospective, Multi-Center, Single-Arm, Real- World Study Assessing Clinical Use of the Bard® UltraScolre™
Focused Force PTA Balloon, CR Bard
Sub-Investigator VALDECOXIB Trial
Principal Investigator An Open-Label, Multinational, Multi-Center, Extension Trial to Assess the Long-Term Safety and Efficacy of ZD4522 in Subjects in
the ZD4522 Clinical Trial Program
BASIC RESEARCH
1990 – 1993 Systematic assessment of Medtronic balloons and guiding catheters in porcine and Canine models. Sponsored by Medtronic, Inc.
1990 – 1993 Determination of radiopacity and torquability of Medtronic vascular catheters in Porcine models. Sponsored by Medtronic, Inc.
1990 – 1994 Evaluation of Japan Crescent radiofrequency balloon in porcine model with emphasis On Histopathology of heat-produced lesions. Abstract
submitted at 1993 AHA Conference.
1992 – 1996 Evaluation of Strecker in porcine and canine models. Sponsored by Boston Scientific. Evaluation of Wiktor stent and stent in porcine and canine
models. Sponsored by Medtronic, Inc. Evaluation of NIR stent in porcine models. Sponsored by Cordis Corp.
1993 Evaluation of radiofrequency wire for total coronary occlusions in porcine models: Determining energy limitations. Equipment subsequently
licensed to Radius Medical.
1994 – 1997 Training courses for professionals (physicians, engineers, technicians) in techniques and
Strategies for placement of coronary stents. Five courses sponsored by Johnson & Johnson, Medtronic, Inc., and Cook, Inc.
1997 Efficacy of the Endotex Abdominal Aortic Aneurysm exclusion device in a porcine
Model gauging ability to exclude renal arteries, ease of placement and radiopacity. Sponsored by Endotex.
1998 Use of percutaneous myocardial revascularization in a porcine model. Sponsored by ardiogenesis Corporation at Stanford University.
1998 – 1999 Utility of radiofrequency (RF) percutaneous myocardial revascularization in acute and chronic porcine model: Histopathology and angiogensis
related to use of RF alone and in combination with growth factor (VEGF). Results presented at Angiogenesis 1999, Washington, D.C.
1999 Development and testing of embolic probe device in porcine model. Performed at PRMC
And separately at Columbia Presbyterian in New York (Patent #6,364,900).
1999 Evaluation of the Medtronic carotid and SVG stent in porcine carotid and saphenous vein graft lesions assessing ease of use and 30-day
outcome. Sponsored by Medtronic, Inc.
1999 Development and testing of Protector vascular embolic protection device in porcine Model at Mayo Clinic (Patent #6,364,900).
1999 Evaluation of ability of intramuscular growth factor to stimulate angiogenesis in rabbit hindlimb model at 30 and 60 days post-procedure.
Sponsored by Sulzer Medical.
1999 Use of Vesseal device to close porcine peripheral artery tears (Patent #6,159,197). Sponsored by Phoenix Heart Center.
2004 Feasibility of device for fluid removal with porcine model. Sponsored by Transvivo, Inc.
2004 Feasibility of PVI in creating AV Fistulae with porcine model. Sponsored by PVI (Patent #6,464,665).
2005 PFO Closure with StarClose Device. Sponsored by NMT.
2006 New RF wire for coronary and peripheral arteries. Sponsored by Radius Medical.
2006 Snare evaluation for heart and neuro application. Sponsored by Radius Medical.
2007 Surrogate endpoints in PAD. Sponsored by TBD.
2007 PFO and Arrhythmias. Sponsored by Phoenix Heart Center.
2008 Porcine Ventricular Closure Star Close. Sponsored by Abbott.
2008 Ventricular Porcine Closure. Sponsored by Medtronic.
2008 Porcine Ventricular Closure. Sponsored by Edwards.
2008 Cerebral Canine studies. Sponsored by Atrium.
2008 Ventricular Closure with AngioLink.
2010 Transapical Closure in Sheep and Pigs. Access Closure, San Jose, California.
2010 Ventricular Closure Ovoic. Sponsored by Access Closure.
2011 Canine PFO. Sponsored by Gore.